Role of ginsenosides in reactive oxygen species-mediated anticancer therapy
Authors:
Open Access
- 19 December 2017
- journal article
- review article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 9 (2) , 2931-2950
Abstract
Role of ginsenosides in reactive oxygen species-mediated anticancer therapy Role of ginsenosides in reactive oxygen species-mediated anticancer therapyKeywords
This publication has 103 references indexed in Scilit:
- A ginseng metabolite, compound K, induces autophagy and apoptosis via generation of reactive oxygen species and activation of JNK in human colon cancer cellsCell Death & Disease, 2013
- Paraptosis and NF-κB activation are associated with protopanaxadiol-induced cancer chemopreventionBMC Complementary and Alternative Medicine, 2013
- Oxidative stress and cancer: An overviewAgeing Research Reviews, 2013
- Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53Cancer Letters, 2011
- Isolation and analysis of ginseng: advances and challengesNatural Product Reports, 2011
- Regulation of cancer cell metabolismNature Reviews Cancer, 2011
- Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicityProceedings of the National Academy of Sciences, 2010
- Antioxidants potentiate American ginseng-induced killing of colorectal cancer cellsCancer Letters, 2010
- Perspectives for Cancer Prevention With Natural CompoundsJournal of Clinical Oncology, 2009
- Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and p38 Signaling PathwaysScience, 1997